SE9700135D0 - New formulation - Google Patents
New formulationInfo
- Publication number
- SE9700135D0 SE9700135D0 SE9700135A SE9700135A SE9700135D0 SE 9700135 D0 SE9700135 D0 SE 9700135D0 SE 9700135 A SE9700135 A SE 9700135A SE 9700135 A SE9700135 A SE 9700135A SE 9700135 D0 SE9700135 D0 SE 9700135D0
- Authority
- SE
- Sweden
- Prior art keywords
- new formulation
- formulation
- useful
- treatment
- dry powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9700135A SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | New formulation |
ZA9878A ZA9878B (en) | 1997-01-20 | 1998-01-06 | New formulation for inhalation |
US09/004,902 US6030604A (en) | 1997-01-20 | 1998-01-09 | Formulation for inhalation |
PCT/SE1998/000040 WO1998031352A1 (en) | 1997-01-20 | 1998-01-13 | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
EEP199900295A EE03951B1 (et) | 1997-01-20 | 1998-01-13 | Inhaleeritav ravimvorm puistetihedusega 0,28 kuni0,38 g/ml, selle valmistamise protsess ja kasutamine |
PT98901618T PT1007017E (pt) | 1997-01-20 | 1998-01-13 | Nova formulacao para inalacao possuindo uma massa volumica aparente de 0,28 a 0,38 g/ml, um processo para a sua preparacao formulacao e sua utilizacao |
IL13083898A IL130838A (en) | 1997-01-20 | 1998-01-13 | Formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
SK959-99A SK283950B6 (sk) | 1997-01-20 | 1998-01-13 | Inhalačná kompozícia, spôsob jej prípravy a jej použitie na prípravu liečiva |
TR1999/01690T TR199901690T2 (xx) | 1997-01-20 | 1998-01-13 | Yeni solunum form�lasyonu, form�lasyonu haz�rlamaya y�nelik i�lem. |
EP98901618A EP1007017B2 (en) | 1997-01-20 | 1998-01-13 | Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof |
IDW990663A ID21865A (id) | 1997-01-20 | 1998-01-13 | Formulasi untuk inhalasi yang mempunyai densitas ruah tertuang 0,28 sampai 0,38 g/ml, proses pembuatan dan penggunaannya |
CNB988019000A CN1271993C (zh) | 1997-01-20 | 1998-01-13 | 注入堆积密度为0.28~0.38g/ml的吸入用新配方、该配方的制备方法及其用途 |
DE69828886T DE69828886T3 (de) | 1997-01-20 | 1998-01-13 | Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, verfahren zur herstellung der formulierung sowie anwendung derselben |
RU99118587/14A RU2194497C2 (ru) | 1997-01-20 | 1998-01-13 | Новый препарат для ингаляции, имеющий насыпную объемную плотность от 0,28 до 0,38 г/мл, способ его получения и его применение |
AT98901618T ATE288260T1 (de) | 1997-01-20 | 1998-01-13 | Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, verfahren zur herstellung der formulierung sowie anwendung derselben |
AU57859/98A AU731192B2 (en) | 1997-01-20 | 1998-01-13 | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
ES98901618T ES2235311T5 (es) | 1997-01-20 | 1998-01-13 | Formulación de budesónida/formoterol para inhalación que tiene una desidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma. |
SI9830754T SI1007017T2 (sl) | 1997-01-20 | 1998-01-13 | Budezonid/formoterol formulacija za inhaliranje, ki ima nasipno gostoto od 0,30 g/ml do 0,36 g/ml, postopek za pripravo formulacije in njena uporaba |
KR10-1999-7006414A KR100528416B1 (ko) | 1997-01-20 | 1998-01-13 | 0.28 내지 0.38 g/㎖의 유동 벌크 밀도를 갖는 신규 흡입 제제, 그의 제조 방법 및 그의 용도 |
NZ336594A NZ336594A (en) | 1997-01-20 | 1998-01-13 | Formulation for inhalation which includes a carrier (lactose, glucose, raffinose, melezitose, lactitol, trehalose, sucrose, mannitol or starch |
JP1998534218A JP4512204B6 (ja) | 1997-01-20 | 1998-01-13 | 0.28から0.38g/mlのかさ密度を有する吸入用新規製剤、その製剤を調製する方法およびその使用 |
PL334527A PL192115B1 (pl) | 1997-01-20 | 1998-01-13 | Sucha kompozycja proszkowa, sposób jej wytwarzania oraz jej zastosowanie |
UA99074044A UA57764C2 (uk) | 1997-01-20 | 1998-01-13 | Суха порошкова композиція, спосіб її виготовлення та спосіб лікування |
CA002277913A CA2277913C (en) | 1997-01-20 | 1998-01-13 | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
HU0000714A HU228622B1 (en) | 1997-01-20 | 1998-01-13 | Budesonide/formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof |
DK98901618.3T DK1007017T4 (da) | 1997-01-20 | 1998-01-13 | Formulering af budesonid/formoterol til inhalering, som har en hældebulkdensitet på 0,30 til 0,36 g/ml, en fremgangsmåde til fremstilling af formuleringen og anvendelsen deraf |
BR9811249-0A BR9811249A (pt) | 1997-01-20 | 1998-01-13 | Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma |
CZ0255799A CZ296301B6 (cs) | 1997-01-20 | 1998-01-13 | Suchý práskový prostredek, zpusob jeho prípravy alécivo s jeho obsahem |
MYPI98000164A MY132999A (en) | 1997-01-20 | 1998-01-15 | New formulation for inhalation |
ARP980100224A AR011080A1 (es) | 1997-01-20 | 1998-01-19 | Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento |
SA98180818A SA98180818B1 (ar) | 1997-01-20 | 1998-02-10 | صياغة جديدة للاستنشاق |
TW087103589A TW557217B (en) | 1997-01-20 | 1998-03-11 | Pharmaceutical dry powder compositions for use in treating respiratory disorders and the process for preparing the same |
IS5108A IS2788B (is) | 1997-01-20 | 1999-07-06 | Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar |
NO19993539A NO327426B1 (no) | 1997-01-20 | 1999-07-19 | Torrpulverpreparat, fremgangsmate for fremstilling samt anvendelse av nevnte preparat |
US09/431,916 US6287540B1 (en) | 1997-01-20 | 1999-11-02 | Formulation for inhalation |
HK00104814A HK1025515A1 (en) | 1997-01-20 | 2000-08-01 | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
JP2009255070A JP2010059181A (ja) | 1997-01-20 | 2009-11-06 | 0.28から0.38g/mlのかさ密度を有する吸入用新規製剤、その製剤を調製する方法およびその使用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9700135A SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9700135D0 true SE9700135D0 (sv) | 1997-01-20 |
Family
ID=20405455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9700135A SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | New formulation |
Country Status (35)
Country | Link |
---|---|
US (2) | US6030604A (et) |
EP (1) | EP1007017B2 (et) |
JP (1) | JP2010059181A (et) |
KR (1) | KR100528416B1 (et) |
CN (1) | CN1271993C (et) |
AR (1) | AR011080A1 (et) |
AT (1) | ATE288260T1 (et) |
AU (1) | AU731192B2 (et) |
BR (1) | BR9811249A (et) |
CA (1) | CA2277913C (et) |
CZ (1) | CZ296301B6 (et) |
DE (1) | DE69828886T3 (et) |
DK (1) | DK1007017T4 (et) |
EE (1) | EE03951B1 (et) |
ES (1) | ES2235311T5 (et) |
HK (1) | HK1025515A1 (et) |
HU (1) | HU228622B1 (et) |
ID (1) | ID21865A (et) |
IL (1) | IL130838A (et) |
IS (1) | IS2788B (et) |
MY (1) | MY132999A (et) |
NO (1) | NO327426B1 (et) |
NZ (1) | NZ336594A (et) |
PL (1) | PL192115B1 (et) |
PT (1) | PT1007017E (et) |
RU (1) | RU2194497C2 (et) |
SA (1) | SA98180818B1 (et) |
SE (1) | SE9700135D0 (et) |
SI (1) | SI1007017T2 (et) |
SK (1) | SK283950B6 (et) |
TR (1) | TR199901690T2 (et) |
TW (1) | TW557217B (et) |
UA (1) | UA57764C2 (et) |
WO (1) | WO1998031352A1 (et) |
ZA (1) | ZA9878B (et) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US6495167B2 (en) | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
US6503537B2 (en) | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
GB9826284D0 (en) * | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
GB9826286D0 (en) * | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
WO2000035417A1 (en) * | 1998-12-11 | 2000-06-22 | Pharmachemie B.V. | Pharmaceutical preparation for inhalation of an opioid |
US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
US6623760B1 (en) * | 1999-01-28 | 2003-09-23 | Schering Corporation | Method of preparing particles for agglomeration |
AR022695A1 (es) * | 1999-01-28 | 2002-09-04 | Schering Corp | PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
GB9904919D0 (en) * | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
AU779869B2 (en) * | 1999-04-13 | 2005-02-17 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility |
CA2273585A1 (en) | 1999-05-28 | 2000-11-28 | Canpolar East Inc. | Sensors for detecting changes in temperature, ph, chemical conditions, biological conditions, radiation, electrical field and pressure |
DE19962926A1 (de) * | 1999-12-24 | 2001-06-28 | Bayer Ag | Verfahren zur Co-Mahlung von Stoffen und Lactose mittels Strahlmühlen |
US6369115B1 (en) * | 2000-03-20 | 2002-04-09 | Dura Pharmaceuticals, Inc. | Stabilized powder formulations |
AU2001252350A1 (en) * | 2000-04-13 | 2001-10-30 | Innovata Biomed Limited | Medicaments for treating respiratory disorders comprising formoterol and fluticasone |
GB0012261D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
CA2417973A1 (en) * | 2000-08-04 | 2002-02-14 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
FI20002177A0 (fi) * | 2000-10-02 | 2000-10-02 | Orion Yhtymae Oyj | Uusi yhdistelmä astman hoitoon |
FI20002216A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
FI20002215A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
ATE369121T1 (de) * | 2001-02-06 | 2007-08-15 | Innovata Biomed Ltd | Bimodale trockenpulverzusammensetzung zur inhalation |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
MXPA04011018A (es) * | 2002-05-07 | 2005-01-25 | Altana Pharma Ag | Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias. |
US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
GB0219512D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions with high drug ratios |
AU2003269989B8 (en) * | 2002-08-21 | 2009-11-12 | Norton Healthcare Ltd. | Inhalation composition |
GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
CA2500065A1 (en) * | 2002-09-30 | 2004-04-15 | Acusphere, Inc. | Sustained release porous microparticles for inhalation |
US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
DK1572217T3 (da) * | 2002-12-12 | 2008-12-15 | Nycomed Gmbh | Kombinationsmedikament af R,R-formoterol og ciclesonid |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
EP1452179A1 (en) * | 2003-02-27 | 2004-09-01 | CHIESI FARMACEUTICI S.p.A. | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
US20040191176A1 (en) * | 2003-03-28 | 2004-09-30 | Kaplan Leonard W | Formulations for treatment of pulmonary disorders |
AU2004241746A1 (en) * | 2003-05-22 | 2004-12-02 | Nycomed Gmbh | Salmeterol and ciclesonide combination |
SE526509C2 (sv) * | 2003-06-19 | 2005-09-27 | Microdrug Ag | Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd |
SE526850C2 (sv) * | 2003-06-19 | 2005-11-08 | Microdrug Ag | Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd |
SE527200C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av formaterol och fluticason |
SE527190C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid |
SE527189C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel |
TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
GB0316335D0 (en) * | 2003-07-11 | 2003-08-13 | Glaxo Group Ltd | Pharmaceutical formulations |
ATE498394T1 (de) | 2003-09-02 | 2011-03-15 | Norton Healthcare Ltd | Verfahren zur herstellung eines medikaments |
US8371292B2 (en) * | 2003-09-16 | 2013-02-12 | Nycomed Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
DE602005002930T2 (de) * | 2004-01-22 | 2008-07-24 | Pfizer Inc. | Sulfonamidderivate zur behandlung von krankheiten |
JO3102B1 (ar) * | 2004-03-17 | 2017-09-20 | Chiesi Framaceutici S P A | صيغ صيدلانية لوسائل استنشاق بها مسحوق جاف تشتمل على مكون فعال بقوة منخفضة الجرعة |
AR048339A1 (es) * | 2004-03-24 | 2006-04-19 | Chiesi Farma Spa | Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion |
US20070134165A1 (en) * | 2004-04-20 | 2007-06-14 | Altana Pharma Ag | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
EP1744800B1 (en) | 2004-04-21 | 2016-06-22 | Innovata Biomed Limited | Inhaler |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
WO2006064283A1 (en) * | 2004-12-17 | 2006-06-22 | Cipla Limited | Pharmaceutical compounds and compositions |
CN104177448A (zh) * | 2005-02-10 | 2014-12-03 | 葛兰素集团有限公司 | 使用预分选技术制备乳糖的方法以及由此形成的药物制剂 |
ES2384641T3 (es) | 2005-07-14 | 2012-07-10 | Lithera, Inc. | Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo |
CN103462943A (zh) * | 2005-07-15 | 2013-12-25 | Map药物公司 | 在离散的吸入粒子中结合的多种活性药物成分及其制剂 |
WO2007009164A1 (en) * | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
EP1973523A2 (en) * | 2005-12-15 | 2008-10-01 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
US20070148211A1 (en) * | 2005-12-15 | 2007-06-28 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for oral administration |
US7913223B2 (en) * | 2005-12-16 | 2011-03-22 | Dialogic Corporation | Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system |
PL2077830T3 (pl) * | 2006-10-17 | 2013-04-30 | Lithera Inc | Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej |
WO2008100727A2 (en) | 2007-02-14 | 2008-08-21 | The Trustees Of Columbia University In The City Of New York | High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders |
ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
GB0714134D0 (en) * | 2007-07-19 | 2007-08-29 | Norton Healthcare Ltd | Dry-powder medicament |
DE102007049931A1 (de) | 2007-10-18 | 2009-04-23 | Pharmatech Gmbh | Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten |
US20100120737A1 (en) * | 2008-11-10 | 2010-05-13 | Martin Feth | Amorphous ciclesonide |
US20100291221A1 (en) * | 2009-05-15 | 2010-11-18 | Robert Owen Cook | Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation |
US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
CA2763939A1 (en) * | 2009-05-29 | 2010-12-02 | Pearl Therapeutics, Inc. | Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
KR20120113267A (ko) * | 2010-01-15 | 2012-10-12 | 리쎄라 인코오포레이티드 | 동결건조 케이크 제제 |
WO2011110852A1 (en) | 2010-03-10 | 2011-09-15 | Astrazeneca Ab | Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
US10179139B2 (en) | 2010-10-12 | 2019-01-15 | Cipla Limited | Pharmaceutical composition |
GEP201606551B (en) | 2010-11-24 | 2016-10-10 | Novamedica Llc | Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging |
US9402854B2 (en) | 2012-04-11 | 2016-08-02 | Cipla Limited | Pharmaceutical composition |
RU2510267C2 (ru) * | 2012-06-15 | 2014-03-27 | Шолекс Девелопмент Гмбх | Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения |
KR102391332B1 (ko) | 2013-03-15 | 2022-04-26 | 펄 테라퓨틱스 인코포레이티드 | 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템 |
PL2821061T3 (pl) | 2013-07-01 | 2018-05-30 | Arven Ilac Sanayi Ve Ticaret A.S. | Nowe preparaty do inhalacji |
CA3073195A1 (en) | 2017-08-15 | 2019-02-21 | Nephron Pharmaceuticals Corporation | Aqueous nebulization composition |
MX2021014343A (es) * | 2019-05-24 | 2022-01-06 | Glenmark Pharmaceutical Ltd | Una composicion de polvo inhalable de dosis fijas que comprende glicopirronio, formoterol y propionato de fluticasona. |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
US4161516A (en) † | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
GB1571629A (en) * | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
CY1492A (en) * | 1981-07-08 | 1990-02-16 | Draco Ab | Powder inhalator |
SE438261B (sv) * | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
DE3268533D1 (en) * | 1981-07-24 | 1986-02-27 | Fisons Plc | Inhalation drugs, methods for their production and pharmaceutical formulations containing them |
GB8825541D0 (en) † | 1988-11-01 | 1988-12-07 | Fisons Plc | Formulation |
EP0705614B1 (en) * | 1989-04-28 | 2002-09-25 | Riker Laboratories, Inc. | Dry powder inhalation device |
US5176132A (en) * | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
ES2044710T3 (es) † | 1990-01-29 | 1994-01-01 | Ciba Geigy Ag | Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina. |
US5192548A (en) * | 1990-04-30 | 1993-03-09 | Riker Laboratoires, Inc. | Device |
SE9100341D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroids |
SE9100342D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroid esters |
SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
SE9101090D0 (sv) * | 1991-04-11 | 1991-04-11 | Astra Ab | Process for conditioning of water-soluble substances |
PT656207E (pt) * | 1991-06-10 | 2001-11-30 | Schering Corp | Formulacoes de aerossois sem clorofluorocarbonetos |
US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
CA2356145A1 (en) * | 1991-12-18 | 1993-06-24 | Aktiebolaget Astra | New combination of formoterol and budesonide |
US5355872B1 (en) * | 1992-03-04 | 1998-10-20 | John H Riggs | Low flow rate nebulizer apparatus and method of nebulization |
ES2177544T3 (es) † | 1992-06-12 | 2002-12-16 | Teijin Ltd | Polvo ultrafinno para inhalar y metodo para su preparacion. |
CA2147283C (en) * | 1992-10-16 | 2007-01-16 | Kouichi Nakamichi | Method of manufacturing wax matrices |
ES2125483T3 (es) * | 1993-08-18 | 1999-03-01 | Unilever Nv | Composicion para el afeitado. |
IS1736B (is) * | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
HU222355B1 (hu) † | 1993-10-01 | 2003-06-28 | Astra Aktiebolag | Eljárás és berendezés finom gyógyszerhatóanyag-porok kezelésére és feldolgozására |
GB9404945D0 (en) † | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
US5503869A (en) * | 1994-10-21 | 1996-04-02 | Glaxo Wellcome Inc. | Process for forming medicament carrier for dry powder inhalator |
US5647347A (en) * | 1994-10-21 | 1997-07-15 | Glaxo Wellcome Inc. | Medicament carrier for dry powder inhalator |
US5654007A (en) * | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
SE9603669D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
-
1997
- 1997-01-20 SE SE9700135A patent/SE9700135D0/xx unknown
-
1998
- 1998-01-06 ZA ZA9878A patent/ZA9878B/xx unknown
- 1998-01-09 US US09/004,902 patent/US6030604A/en not_active Expired - Lifetime
- 1998-01-13 ES ES98901618T patent/ES2235311T5/es not_active Expired - Lifetime
- 1998-01-13 EE EEP199900295A patent/EE03951B1/et unknown
- 1998-01-13 NZ NZ336594A patent/NZ336594A/xx not_active IP Right Cessation
- 1998-01-13 HU HU0000714A patent/HU228622B1/hu unknown
- 1998-01-13 RU RU99118587/14A patent/RU2194497C2/ru active
- 1998-01-13 DK DK98901618.3T patent/DK1007017T4/da active
- 1998-01-13 SI SI9830754T patent/SI1007017T2/sl unknown
- 1998-01-13 ID IDW990663A patent/ID21865A/id unknown
- 1998-01-13 PL PL334527A patent/PL192115B1/pl unknown
- 1998-01-13 EP EP98901618A patent/EP1007017B2/en not_active Expired - Lifetime
- 1998-01-13 KR KR10-1999-7006414A patent/KR100528416B1/ko active IP Right Grant
- 1998-01-13 PT PT98901618T patent/PT1007017E/pt unknown
- 1998-01-13 DE DE69828886T patent/DE69828886T3/de not_active Expired - Lifetime
- 1998-01-13 AU AU57859/98A patent/AU731192B2/en not_active Expired
- 1998-01-13 CN CNB988019000A patent/CN1271993C/zh not_active Expired - Lifetime
- 1998-01-13 WO PCT/SE1998/000040 patent/WO1998031352A1/en active IP Right Grant
- 1998-01-13 SK SK959-99A patent/SK283950B6/sk not_active IP Right Cessation
- 1998-01-13 TR TR1999/01690T patent/TR199901690T2/xx unknown
- 1998-01-13 BR BR9811249-0A patent/BR9811249A/pt not_active Application Discontinuation
- 1998-01-13 AT AT98901618T patent/ATE288260T1/de active
- 1998-01-13 CZ CZ0255799A patent/CZ296301B6/cs not_active IP Right Cessation
- 1998-01-13 CA CA002277913A patent/CA2277913C/en not_active Expired - Lifetime
- 1998-01-13 IL IL13083898A patent/IL130838A/xx not_active IP Right Cessation
- 1998-01-13 UA UA99074044A patent/UA57764C2/uk unknown
- 1998-01-15 MY MYPI98000164A patent/MY132999A/en unknown
- 1998-01-19 AR ARP980100224A patent/AR011080A1/es not_active Application Discontinuation
- 1998-02-10 SA SA98180818A patent/SA98180818B1/ar unknown
- 1998-03-11 TW TW087103589A patent/TW557217B/zh not_active IP Right Cessation
-
1999
- 1999-07-06 IS IS5108A patent/IS2788B/is unknown
- 1999-07-19 NO NO19993539A patent/NO327426B1/no not_active IP Right Cessation
- 1999-11-02 US US09/431,916 patent/US6287540B1/en not_active Expired - Lifetime
-
2000
- 2000-08-01 HK HK00104814A patent/HK1025515A1/xx not_active IP Right Cessation
-
2009
- 2009-11-06 JP JP2009255070A patent/JP2010059181A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9700135D0 (sv) | New formulation | |
SE9700133D0 (sv) | New formulation | |
SE9700134D0 (sv) | New formulation | |
SE9700136D0 (sv) | New formulation |